{"id":5624,"date":"2025-02-06T12:00:00","date_gmt":"2025-02-06T12:00:00","guid":{"rendered":"https:\/\/leyton.majjane.agency\/us\/?p=5624"},"modified":"2026-07-26T16:24:45","modified_gmt":"2026-07-26T14:24:45","slug":"navigating-state-and-local-tax-challenges-in-the-biotech-industry","status":"publish","type":"article","link":"https:\/\/leyton.com\/us\/insights\/articles\/navigating-state-and-local-tax-challenges-in-the-biotech-industry\/","title":{"rendered":"SALT and the Biotech Industry"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">The biotechnology industry is a <strong><mark class=\"has-inline-color has-luminous-vivid-amber-color\">rapidly evolving<\/mark><\/strong> sector that requires significant investment in research and development, infrastructure, and talent. However, with this growth comes a complex <a href=\"https:\/\/leyton.com\/us\/state-and-local-tax-s-a-l-t\/?utm_source=article&amp;utm_medium=article&amp;utm_term=&amp;utm_content=Link&amp;utm_campaign=biotechxsalt\"><mark class=\"has-inline-color has-luminous-vivid-amber-color\">State and Local Tax (SALT)<\/mark><\/a><mark class=\"has-inline-color has-luminous-vivid-amber-color\"> <\/mark>landscape that CPAs must navigate to help biotech firms optimize their tax positions and ensure compliance. From income approval to sales tax exemptions, understanding the intricacies of SALT can provide biotech companies with strategic advantages.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Key SALT Considerations for Biotech Industry<\/h2>\n\n\n\n<h2 class=\"wp-block-heading\">1. Income Tax Apportionment and Nexus<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Biotech companies often operate in multiple states, leading to complex <strong><mark class=\"has-inline-color has-luminous-vivid-amber-color\">income tax apportionment issues<\/mark><\/strong>. Some states use a three-factor formula\u2014sales, property, and payroll\u2014to determine tax liability, while others emphasize sales under a single-sales factor approach. CPAs should analyze each state\u2019s rules to minimize exposure and take advantage of beneficial <strong><mark class=\"has-inline-color has-luminous-vivid-amber-color\">apportionment<\/mark><\/strong> methodologies.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Additionally, economic nexus standards introduced by states <strong><mark class=\"has-inline-color has-luminous-vivid-amber-color\">post-Wayfair<\/mark><\/strong> have increased compliance burdens. Biotech firms that conduct research or sell products in multiple jurisdictions may trigger tax obligations even without a physical presence, necessitating careful <strong><mark class=\"has-inline-color has-luminous-vivid-amber-color\">nexus analysis<\/mark><\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">2. Sales and Use Tax Exemptions<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Many states offer sales and use tax exemptions for equipment and supplies used in research and development (R&amp;D). CPAs should ensure that biotech clients take <strong><mark class=\"has-inline-color has-luminous-vivid-amber-color\">full advantage<\/mark><\/strong> of these exemptions by properly documenting qualifying purchases and filing exemption certificates where applicable.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Additionally, exemptions may extend to purchases of lab equipment, chemicals, and prototype development materials. Some states also provide relief for <strong><mark class=\"has-inline-color has-luminous-vivid-amber-color\">software and cloud-based services<\/mark><\/strong> integral to biotech research.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">3. R&amp;D Tax Credits and Incentives<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">While federal R&amp;D tax credits are well-known, states also offer their own incentives that can significantly reduce <strong><mark class=\"has-inline-color has-luminous-vivid-amber-color\">tax liability<\/mark><\/strong>. Many states provide refundable or transferable R&amp;D credits, allowing biotech firms\u2014many of which operate at a loss during early-stage development\u2014to monetize these credits effectively. CPAs should identify which credits apply to their clients and assist in filing the necessary documentation.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">4. Property and Payroll Tax Considerations<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Biotech firms investing in laboratory facilities or manufacturing plants may be eligible for property tax abatements, particularly in jurisdictions promoting <strong><mark class=\"has-inline-color has-luminous-vivid-amber-color\">biotech innovation<\/mark><\/strong>. Some states and localities also offer payroll tax incentives for job creation in the biotech sector. CPAs should explore available incentives and ensure compliance with employment-related tax obligations, particularly for multistate payroll operations.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">5. State-Specific Biotech Industry Incentives<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Several states have targeted incentive programs designed specifically for biotech firms. For example:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong><mark class=\"has-inline-color has-luminous-vivid-amber-color\">Massachusetts<\/mark><\/strong> offers biotech investment tax credits and grants through the Massachusetts Life Sciences Center.<\/li>\n<li><mark class=\"has-inline-color has-luminous-vivid-amber-color\"><strong>California<\/strong> <\/mark>provides partial sales tax exemptions on R&amp;D equipment.<\/li>\n<li><mark class=\"has-inline-color has-luminous-vivid-amber-color\"><strong>Maryland<\/strong> <\/mark>has a biotech investment incentive tax credit to attract early-stage investors.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">It\u2019s important that CPAs remain up to date on state-specific programs and help biotech firms maximize available benefits.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Compliance and Strategic Planning for the Biotech Industry<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Given the complexity of state and local tax laws, proactive<strong><mark class=\"has-inline-color has-luminous-vivid-amber-color\"> compliance strategies<\/mark><\/strong> are essential. Biotech firms should conduct regular<a href=\"https:\/\/leyton.com\/us\/state-and-local-tax-s-a-l-t\/?utm_source=article&amp;utm_medium=article&amp;utm_term=&amp;utm_content=Link&amp;utm_campaign=biotechxsalt\"> <mark class=\"has-inline-color has-luminous-vivid-amber-color\">SALT<\/mark> <\/a>reviews, leverage tax automation software, and work closely with CPAs to mitigate risks and uncover opportunities.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">As the biotech industry continues to expand, CPAs play a <strong><mark class=\"has-inline-color has-luminous-vivid-amber-color\">crucial role<\/mark><\/strong> in guiding companies through the evolving tax landscape. By staying informed on state and local tax developments, CPAs can help biotech clients remain competitive, compliant, and financially efficient in their operations.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Want to discuss this further? Schedule a call with our experts below!<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Discover key state and local tax (SALT) strategies for the biotech industry, including income tax apportionment, R&#038;D credits, sales tax exemptions, and state-specific incentives.<\/p>\n","protected":false},"author":1,"featured_media":1441,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","format":"standard","meta":{"_acf_changed":false,"_leyton_l4m_sync":false,"footnotes":""},"categories":[289,429],"tags":[],"expertise":[],"class_list":["post-5624","article","type-article","status-publish","format-standard","has-post-thumbnail","hentry","category-life-sciences-en","category-state-local-tax-salt-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.1 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>SALT and the Biotech Industry - Leyton United States<\/title>\n<meta name=\"description\" content=\"Discover key state and local tax (SALT) strategies for the biotech industry, including income tax apportionment, R&amp;D credits, sales tax exemptions, and state-sp\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/leyton.com\/us\/insights\/articles\/navigating-state-and-local-tax-challenges-in-the-biotech-industry\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SALT and the Biotech Industry\" \/>\n<meta property=\"og:description\" content=\"Discover key state and local tax (SALT) strategies for the biotech industry, including income tax apportionment, R&amp;D credits, sales tax exemptions, and state-sp\" \/>\n<meta property=\"og:url\" content=\"https:\/\/leyton.com\/us\/insights\/articles\/navigating-state-and-local-tax-challenges-in-the-biotech-industry\/\" \/>\n<meta property=\"og:site_name\" content=\"Leyton\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-26T14:24:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/leyton.com\/wp-content\/blogs.dir\/4\/files\/2025\/02\/USA-PPT-Photos-650-x-360-px-4.png\" \/>\n\t<meta property=\"og:image:width\" content=\"650\" \/>\n\t<meta property=\"og:image:height\" content=\"360\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/leyton.com\\\/us\\\/insights\\\/articles\\\/navigating-state-and-local-tax-challenges-in-the-biotech-industry\\\/\",\"url\":\"https:\\\/\\\/leyton.com\\\/us\\\/insights\\\/articles\\\/navigating-state-and-local-tax-challenges-in-the-biotech-industry\\\/\",\"name\":\"SALT and the Biotech Industry - Leyton United States\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/leyton.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/leyton.com\\\/us\\\/insights\\\/articles\\\/navigating-state-and-local-tax-challenges-in-the-biotech-industry\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/leyton.com\\\/us\\\/insights\\\/articles\\\/navigating-state-and-local-tax-challenges-in-the-biotech-industry\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/leyton.com\\\/wp-content\\\/blogs.dir\\\/4\\\/files\\\/2025\\\/02\\\/USA-PPT-Photos-650-x-360-px-4.png\",\"datePublished\":\"2025-02-06T12:00:00+00:00\",\"dateModified\":\"2026-07-26T14:24:45+00:00\",\"description\":\"Discover key state and local tax (SALT) strategies for the biotech industry, including income tax apportionment, R&D credits, sales tax exemptions, and state-sp\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/leyton.com\\\/us\\\/insights\\\/articles\\\/navigating-state-and-local-tax-challenges-in-the-biotech-industry\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/leyton.com\\\/us\\\/insights\\\/articles\\\/navigating-state-and-local-tax-challenges-in-the-biotech-industry\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/leyton.com\\\/us\\\/insights\\\/articles\\\/navigating-state-and-local-tax-challenges-in-the-biotech-industry\\\/#primaryimage\",\"url\":\"https:\\\/\\\/leyton.com\\\/wp-content\\\/blogs.dir\\\/4\\\/files\\\/2025\\\/02\\\/USA-PPT-Photos-650-x-360-px-4.png\",\"contentUrl\":\"https:\\\/\\\/leyton.com\\\/wp-content\\\/blogs.dir\\\/4\\\/files\\\/2025\\\/02\\\/USA-PPT-Photos-650-x-360-px-4.png\",\"width\":650,\"height\":360},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/leyton.com\\\/us\\\/insights\\\/articles\\\/navigating-state-and-local-tax-challenges-in-the-biotech-industry\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/leyton.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SALT and the Biotech Industry\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/leyton.com\\\/#website\",\"url\":\"https:\\\/\\\/leyton.com\\\/\",\"name\":\"Leyton\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/leyton.com\\\/us\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/leyton.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/leyton.com\\\/us\\\/#organization\",\"name\":\"Leyton\",\"url\":\"https:\\\/\\\/leyton.com\\\/us\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/leyton.com\\\/us\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/leyton.com\\\/wp-content\\\/blogs.dir\\\/4\\\/files\\\/2026\\\/01\\\/logo.svg\",\"contentUrl\":\"https:\\\/\\\/leyton.com\\\/wp-content\\\/blogs.dir\\\/4\\\/files\\\/2026\\\/01\\\/logo.svg\",\"width\":108,\"height\":44,\"caption\":\"Leyton\"},\"image\":{\"@id\":\"https:\\\/\\\/leyton.com\\\/us\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"SALT and the Biotech Industry - Leyton United States","description":"Discover key state and local tax (SALT) strategies for the biotech industry, including income tax apportionment, R&D credits, sales tax exemptions, and state-sp","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/leyton.com\/us\/insights\/articles\/navigating-state-and-local-tax-challenges-in-the-biotech-industry\/","og_locale":"en_US","og_type":"article","og_title":"SALT and the Biotech Industry","og_description":"Discover key state and local tax (SALT) strategies for the biotech industry, including income tax apportionment, R&D credits, sales tax exemptions, and state-sp","og_url":"https:\/\/leyton.com\/us\/insights\/articles\/navigating-state-and-local-tax-challenges-in-the-biotech-industry\/","og_site_name":"Leyton","article_modified_time":"2026-07-26T14:24:45+00:00","og_image":[{"width":650,"height":360,"url":"https:\/\/leyton.com\/wp-content\/blogs.dir\/4\/files\/2025\/02\/USA-PPT-Photos-650-x-360-px-4.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/leyton.com\/us\/insights\/articles\/navigating-state-and-local-tax-challenges-in-the-biotech-industry\/","url":"https:\/\/leyton.com\/us\/insights\/articles\/navigating-state-and-local-tax-challenges-in-the-biotech-industry\/","name":"SALT and the Biotech Industry - Leyton United States","isPartOf":{"@id":"https:\/\/leyton.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/leyton.com\/us\/insights\/articles\/navigating-state-and-local-tax-challenges-in-the-biotech-industry\/#primaryimage"},"image":{"@id":"https:\/\/leyton.com\/us\/insights\/articles\/navigating-state-and-local-tax-challenges-in-the-biotech-industry\/#primaryimage"},"thumbnailUrl":"https:\/\/leyton.com\/wp-content\/blogs.dir\/4\/files\/2025\/02\/USA-PPT-Photos-650-x-360-px-4.png","datePublished":"2025-02-06T12:00:00+00:00","dateModified":"2026-07-26T14:24:45+00:00","description":"Discover key state and local tax (SALT) strategies for the biotech industry, including income tax apportionment, R&D credits, sales tax exemptions, and state-sp","breadcrumb":{"@id":"https:\/\/leyton.com\/us\/insights\/articles\/navigating-state-and-local-tax-challenges-in-the-biotech-industry\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/leyton.com\/us\/insights\/articles\/navigating-state-and-local-tax-challenges-in-the-biotech-industry\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/leyton.com\/us\/insights\/articles\/navigating-state-and-local-tax-challenges-in-the-biotech-industry\/#primaryimage","url":"https:\/\/leyton.com\/wp-content\/blogs.dir\/4\/files\/2025\/02\/USA-PPT-Photos-650-x-360-px-4.png","contentUrl":"https:\/\/leyton.com\/wp-content\/blogs.dir\/4\/files\/2025\/02\/USA-PPT-Photos-650-x-360-px-4.png","width":650,"height":360},{"@type":"BreadcrumbList","@id":"https:\/\/leyton.com\/us\/insights\/articles\/navigating-state-and-local-tax-challenges-in-the-biotech-industry\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/leyton.com\/us\/"},{"@type":"ListItem","position":2,"name":"SALT and the Biotech Industry"}]},{"@type":"WebSite","@id":"https:\/\/leyton.com\/#website","url":"https:\/\/leyton.com\/","name":"Leyton","description":"","publisher":{"@id":"https:\/\/leyton.com\/us\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/leyton.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/leyton.com\/us\/#organization","name":"Leyton","url":"https:\/\/leyton.com\/us\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/leyton.com\/us\/#\/schema\/logo\/image\/","url":"https:\/\/leyton.com\/wp-content\/blogs.dir\/4\/files\/2026\/01\/logo.svg","contentUrl":"https:\/\/leyton.com\/wp-content\/blogs.dir\/4\/files\/2026\/01\/logo.svg","width":108,"height":44,"caption":"Leyton"},"image":{"@id":"https:\/\/leyton.com\/us\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/leyton.com\/us\/wp-json\/wp\/v2\/article\/5624","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/leyton.com\/us\/wp-json\/wp\/v2\/article"}],"about":[{"href":"https:\/\/leyton.com\/us\/wp-json\/wp\/v2\/types\/article"}],"author":[{"embeddable":true,"href":"https:\/\/leyton.com\/us\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/leyton.com\/us\/wp-json\/wp\/v2\/comments?post=5624"}],"version-history":[{"count":1,"href":"https:\/\/leyton.com\/us\/wp-json\/wp\/v2\/article\/5624\/revisions"}],"predecessor-version":[{"id":5696,"href":"https:\/\/leyton.com\/us\/wp-json\/wp\/v2\/article\/5624\/revisions\/5696"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/leyton.com\/us\/wp-json\/wp\/v2\/media\/1441"}],"wp:attachment":[{"href":"https:\/\/leyton.com\/us\/wp-json\/wp\/v2\/media?parent=5624"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/leyton.com\/us\/wp-json\/wp\/v2\/categories?post=5624"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/leyton.com\/us\/wp-json\/wp\/v2\/tags?post=5624"},{"taxonomy":"expertise","embeddable":true,"href":"https:\/\/leyton.com\/us\/wp-json\/wp\/v2\/expertise?post=5624"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}